{"pmid":32330324,"title":"Acral cutaneous lesions in the Time of COVID-19.","text":["Acral cutaneous lesions in the Time of COVID-19.","Coronavirus disease 2019 (COVID-19) has become a pandemic condition, yet little is known about its dermatologic manifestations. We report here on peculiar (perniosis-like) skin lesions, unreported in the previous years, observed in young outpatients visited in our Dermatologic Unit in the last 4 weeks of COVID-19 pandemic (March-April 2020). Similar cases were referred to us in the same period by Pediatricians and Dermatologists from Italy and European countries.","J Eur Acad Dermatol Venereol","Recalcati, S","Barbagallo, T","Frasin, L A","Prestinari, F","Cogliardi, A","Provero, M C","Dainese, E","Vanzati, A","Fantini, F","32330324"],"abstract":["Coronavirus disease 2019 (COVID-19) has become a pandemic condition, yet little is known about its dermatologic manifestations. We report here on peculiar (perniosis-like) skin lesions, unreported in the previous years, observed in young outpatients visited in our Dermatologic Unit in the last 4 weeks of COVID-19 pandemic (March-April 2020). Similar cases were referred to us in the same period by Pediatricians and Dermatologists from Italy and European countries."],"journal":"J Eur Acad Dermatol Venereol","authors":["Recalcati, S","Barbagallo, T","Frasin, L A","Prestinari, F","Cogliardi, A","Provero, M C","Dainese, E","Vanzati, A","Fantini, F"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330324","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16533","keywords":["covid-19","acral lesions","children","cutaneous manifestations","pediatric population","skin"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Pediatricians","Dermatologists","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"_version_":1664996914780700672,"score":8.518259,"similar":[{"pmid":32294264,"title":"Cutaneous manifestations in COVID-19: a new contribution.","text":["Cutaneous manifestations in COVID-19: a new contribution.","We have read with great interest Dr Recalcati's review about skin manifestations in COVID-19 as it is the first report on this subject(1) . In a recent review on clinical characteristics of coronavirus disease 2019 in China, rash was observed in 0,2% of cases(2) . However, from the trained eyes of a dermatologist, this percentage may be higher.","J Eur Acad Dermatol Venereol","Estebanez, Andrea","Perez-Santiago, Leticia","Silva, Esmeralda","Guillen-Climent, Santiago","Garcia-Vazquez, Alejandro","Ramon, M Dolores","32294264"],"abstract":["We have read with great interest Dr Recalcati's review about skin manifestations in COVID-19 as it is the first report on this subject(1) . In a recent review on clinical characteristics of coronavirus disease 2019 in China, rash was observed in 0,2% of cases(2) . However, from the trained eyes of a dermatologist, this percentage may be higher."],"journal":"J Eur Acad Dermatol Venereol","authors":["Estebanez, Andrea","Perez-Santiago, Leticia","Silva, Esmeralda","Guillen-Climent, Santiago","Garcia-Vazquez, Alejandro","Ramon, M Dolores"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294264","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jdv.16474","keywords":["covid-19","cutaneous","cutaneous manifestations","skin"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664636192544522241,"score":272.2761},{"pmid":32298514,"title":"Non-cutaneous considerations of COVID19 for dermatology practices.","text":["Non-cutaneous considerations of COVID19 for dermatology practices.","COVID19 presents many pressing challenges to the global dermatological community and our patients with ongoing skin needs, which must be considered by every dermatology provider. Many of these are logistical and administrative, distinct from physical manifestations, and could be summarised by the acronym COVID.","J Cosmet Dermatol","Ali, Faisal R","Al-Niaimi, Firas","32298514"],"abstract":["COVID19 presents many pressing challenges to the global dermatological community and our patients with ongoing skin needs, which must be considered by every dermatology provider. Many of these are logistical and administrative, distinct from physical manifestations, and could be summarised by the acronym COVID."],"journal":"J Cosmet Dermatol","authors":["Ali, Faisal R","Al-Niaimi, Firas"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298514","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jocd.13444","keywords":["covid19","coronavirus","dermatology","immunosuppressants","practice management","teledermatology"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664641388438880256,"score":198.38667},{"pmid":32320091,"title":"Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.","text":["Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.","Since the first case of \"pneumonia of unknown aetiology\" was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognised thereafter as \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease-19 (COVID- 19) and satisfying the epidemiological criteria for a label of \"pandemic.\" The ongoing SARS-CoV-2 pandemic is having a huge impact on dermatological practice including the marked reduction of face-to-face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID-19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID-19 care for patients assistance and new research needs to be addressed. It is not known yet, if skin lesions and derangement of the skin barrier could make it easier for SARS-CoV-2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS-CoV-2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS-CoV-2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID-19 disaster. Learning from experience may help to cope with future major societal changes.","J Eur Acad Dermatol Venereol","Gisondi, P","Piaserico, S","Conti, A","Naldi, L","32320091"],"abstract":["Since the first case of \"pneumonia of unknown aetiology\" was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognised thereafter as \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease-19 (COVID- 19) and satisfying the epidemiological criteria for a label of \"pandemic.\" The ongoing SARS-CoV-2 pandemic is having a huge impact on dermatological practice including the marked reduction of face-to-face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID-19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID-19 care for patients assistance and new research needs to be addressed. It is not known yet, if skin lesions and derangement of the skin barrier could make it easier for SARS-CoV-2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS-CoV-2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS-CoV-2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID-19 disaster. Learning from experience may help to cope with future major societal changes."],"journal":"J Eur Acad Dermatol Venereol","authors":["Gisondi, P","Piaserico, S","Conti, A","Naldi, L"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320091","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16515","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664815087646408705,"score":195.87706},{"pmid":32294273,"title":"Urticarial eruption in COVID-19 infection.","text":["Urticarial eruption in COVID-19 infection.","Coronavirus disease (COVID-19) is spreading quickly across the world, until a pandemic condition was announced by the WHO on March. Many clinical manifestations of this virus are described and new symptoms are emerging particularly outside respiratory sphere, such as anosmia and ageusia which are recent ORL published symptoms. About skin manifestation, few cases of rashes on patients with laboratory-confirmed Covid-19 were described in two Chineses cohorts.","J Eur Acad Dermatol Venereol","Henry, D","Ackerman, M","Sancelme, E","Finon, A","Esteve, E","32294273"],"abstract":["Coronavirus disease (COVID-19) is spreading quickly across the world, until a pandemic condition was announced by the WHO on March. Many clinical manifestations of this virus are described and new symptoms are emerging particularly outside respiratory sphere, such as anosmia and ageusia which are recent ORL published symptoms. About skin manifestation, few cases of rashes on patients with laboratory-confirmed Covid-19 were described in two Chineses cohorts."],"journal":"J Eur Acad Dermatol Venereol","authors":["Henry, D","Ackerman, M","Sancelme, E","Finon, A","Esteve, E"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294273","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jdv.16472","keywords":["covid-19","cutaneous","cutaneous manifestations","skin","urticaria"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["Chineses"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664636192546619392,"score":194.61098},{"pmid":32330334,"title":"Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.","text":["Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.","We have recently noticed an outbreak of chilblain-like lesions in Italy contemporarily to COVID-19 epidemic. Due to the well known lockdown-related difficulties to visit the patients(1) we created a Google form aimed to collect information about patients presenting with these singular clinical findings. An easy to access and quick tool was chosen by the investigators in order to permit the other colleagues to spend the least amount of time, given the severe health emergency.","J Eur Acad Dermatol Venereol","Piccolo, Vincenzo","Neri, Iria","Filippeschi, Cesare","Oranges, Teresa","Argenziano, Giuseppe","Battarra, Vincenzo Claudio","Berti, Samantha","Manunza, Francesca","Belloni Fortina, Anna","Di Lernia, Vito","Boccaletti, Valeria","De Bernardis, Giovanna","Brunetti, Bruno","Mazzatenta, Carlo","Bassi, Andrea","32330334"],"abstract":["We have recently noticed an outbreak of chilblain-like lesions in Italy contemporarily to COVID-19 epidemic. Due to the well known lockdown-related difficulties to visit the patients(1) we created a Google form aimed to collect information about patients presenting with these singular clinical findings. An easy to access and quick tool was chosen by the investigators in order to permit the other colleagues to spend the least amount of time, given the severe health emergency."],"journal":"J Eur Acad Dermatol Venereol","authors":["Piccolo, Vincenzo","Neri, Iria","Filippeschi, Cesare","Oranges, Teresa","Argenziano, Giuseppe","Battarra, Vincenzo Claudio","Berti, Samantha","Manunza, Francesca","Belloni Fortina, Anna","Di Lernia, Vito","Boccaletti, Valeria","De Bernardis, Giovanna","Brunetti, Bruno","Mazzatenta, Carlo","Bassi, Andrea"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330334","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16526","keywords":["covid-19","chilblains","coronavirus","cutaneous","pernio"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"_version_":1664996914875072512,"score":191.56734}]}